Abstract

ėŖ©ģ : ė³ø ģ—°źµ¬ėŠ” human papillomavirus (HPV) ź°ģ—¼ź³¼ ķ“ė¼ėÆøė””ģ•„ ź°ģ—¼ģ“ ģžź¶ź²½ė¶€ ģ“ķ˜•ģ„±ģ— ģ˜ķ–„ģ„ ėÆøģ¹˜ėŠ”ģ§€ ģ•Œģ•„ė³“ź³ ģž ķ•˜ģ˜€ė‹¤. ģ—°źµ¬ ė°©ė²•: ģžź¶ź²½ė¶€ ģ•”ģƒģ„øķ¬ģ§„ ź²€ģ‚¬ģ—ģ„œ ė¹„ģ •ģƒģœ¼ė”œ ģ§„ė‹Øėœ ķ™˜ģž 374ėŖ…ģ„ ėŒ€ģƒģœ¼ė”œ ģ”°ģ§ķ•™ģ  ź²€ģ‚¬ģ™€ HPV ė° ķ“ė¼ėÆøė””ģ•„ ź°ģ—¼ģ˜ ģƒź“€ź“€ź³„ė„¼ ģ—°źµ¬ķ•˜ģ˜€ė‹¤. ź²°ź³¼: ģ”°ģ§ķ•™ģ  ź²€ģ‚¬ź²°ź³¼ cervical intraepithelial neoplasia (CIN) 2ź°€ 16ėŖ…, CIN 3ź°€ 55ėŖ…, carcinoma in situ (CIS)ź°€ 53ėŖ…ģ“ģ—ˆģœ¼ė©° ģ•”ģƒ ģ„øķ¬ģ§„ ź²€ģ‚¬ģ—ģ„œėŠ” atypical squamous cells of undetermined significanceģ˜€ģœ¼ė‚˜ high-grade squamous intraepithelial lesions ģ“ģƒģø ź³ ė“±źø‰ ė³‘ė³€ģ“ 22ėŖ…ģ“ģ—ˆģœ¼ė©°, low-grade squamous intraepithelial lesionsźµ°ģ—ģ„œė„ 7ėŖ…ģ“ ź³ ė“±źø‰ ė³‘ė³€ģœ¼ė”œ ķŒģ •ė˜ģ—ˆė‹¤. HPV ź°ģ—¼źµ°ģ€ 235ėŖ…ģ“ź³  ķ“ė¼ėÆøė””ģ•„ ź°ģ—¼źµ°ģ€ 31ėŖ…(8.3%)ģ“ė©°, ė‘ źµ°ģ˜ ė™ģ‹œź°ģ—¼ģ€ 25ėŖ…(6.7%)ģ˜ ė¹ˆė„ė„¼ ė³“ģ˜€ģœ¼ė©° ė™ģ‹œ ź°ģ—¼źµ°ź³¼ ģ”°ģ§ķ•™ģ  ė³‘ė³€ģ˜ ģ•…ģ„±ė„ģ˜ ģƒź“€ź“€ź³„ėŠ” ģ—†ģ—ˆė‹¤(P=0.089). HPV ź°ģ—¼ź³¼ ķ“ė¼ėÆøė””ģ•„ ź°ģ—¼ģ—ėŠ” ģ„ ķ›„ ź“€ź³„ėŠ” ėŖ…ķ™•ķ•˜ģ§€ ģ•Šģœ¼ė‚˜ P=0.022ė”œ ė‘ źµ° ź°„ģ— ģœ ģ˜ķ•œ ģƒź“€ź“€ź³„ź°€ ģ”“ģž¬ķ•œė‹¤ź³  ė³¼ ģˆ˜ ģžˆė‹¤. ź³ ė“±źø‰ CINźµ°ė§Œģ„ ėŒ€ģƒģœ¼ė”œ HPV ė° ķ“ė¼ėÆøė””ģ•„ ź°ģ—¼ģ˜ ķ†µź³„ģ  ģœ ģ˜ģ„±ģ€ P=0.157ė”œ ķ†µź³„ģ  ģœ ģ˜ģ„±ģ€ ģ—†ģ—ˆģœ¼ė©°, ź³ ģœ„ķ—˜ HPV ź°ģ—¼ź³¼ ķ“ė¼ėÆøė””ģ•„ ź°ģ—¼ ė˜ķ•œ P=0.195ė”œ ķ†µź³„ģ  ģƒź“€ź“€ź³„ėŠ” ģ—†ģ—ˆė‹¤. ź²°ė” : ģžź¶ź²½ė¶€ ģƒķ”¼ė‚“ ģ¢…ģ–‘ ķ™˜ģžģ—ģ„œ HPV ź°ģ—¼ģ€ ź·ø ģ—­ķ• ģ“ ė„ė¦¬ ģ•Œė ¤ģ ø ģžˆģœ¼ė‚˜ ķ“ė¼ėÆøė””ģ•„ ź°ģ—¼ź³¼ģ˜ ģ—°ź“€ģ„±ģ— ėŒ€ķ•“ģ„œėŠ”ģ•„ģ§ ė” ė§Žģ€ ģ—°źµ¬ź°€ ģžˆģ–“ģ•¼ ķ•  ź²ƒģœ¼ė”œ ģƒź°ėœė‹¤.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call